Clinical Staging of Alzheimer’s Disease: Concordance of Subjective and Objective Assessments in the Veteran’s Affairs Healthcare System
Authors:
Open Access
- 1 July 2022
- journal article
- research article
- Published by Springer Nature in Neurology and Therapy
- Vol. 11 (3) , 1341-1352
Abstract
Introduction Uncertainty surrounding the accurate assessment of the early-stage Alzheimer’s disease (AD) may cause delayed care and inappropriate patient access to new AD therapies. Methods To analyze clinical assessments of patients with AD in the Veteran’s Affairs (VA) Healthcare System and evaluate concordance between subjective and objective assessments, we processed clinical notes extracted by text integration utilities between April 1, 2008 and October 14, 2021. Veterans who had mild, moderate, or severe AD with clinical notes documenting both clinician’s judgement of AD severity and objective test scores from the Mini-Mental State Examination or the Montreal Cognitive Assessment were included. Using clinician-defined severity cohorts, we determined concordance between the clinician’s (subjective) assessments and the test-derived (objective) assessments of AD severity. Concordance was assessed over time and by selected symptoms and comorbidities, as well as healthcare system factors. Results A total of 8888 notes were initially extracted; the final analysis sample included 7514 notes corresponding to 4469 unique patients (mean [standard deviation] age of 78 [9] years; 96.5% male; 77.8% White). Subjective and objective assessments were concordant in approximately half (53%) of overall notes. In the mild Alzheimer’s cohort, patients were assessed to have more severe disease by objective test scores in 40% of notes. Concordance varied about 21–73%, 47–58%, and 40–64% across symptoms/comorbidities, clinician types, and Veteran’s Integrated Service Networks, respectively. The proportion of concordant notes was higher in visits to dementia (61%) instead of non-dementia clinics (53%). Conclusions We found higher concordance between clinician’s assessment and test-based assessment of Alzheimer’s disease severity in dementia specialty clinics. Discordance is especially high for the subjectively assessed mild AD cohort where objective assessments showed a higher severity level in 40% of notes. These data indicate a critical need for improved understanding of clinical assessments and decision-making to identify appropriate patients for anti-amyloid therapy.Keywords
Funding Information
- National Institute of Aging (RF1AG063913)
- Eisai Incorporated
This publication has 26 references indexed in Scilit:
- Treatment strategies for multiple sclerosis: When to start, when to change, when to stop?World Journal of Clinical Cases, 2015
- Alzheimer's Disease prevalence, costs, and prevention for military personnel and veteransAlzheimer's & Dementia, 2014
- Military risk factors for Alzheimer's diseaseAlzheimer's & Dementia, 2013
- The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's diseaseAlzheimer's & Dementia, 2011
- The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's diseaseAlzheimer's & Dementia, 2011
- A meta-analysis of the accuracy of the mini-mental state examination in the detection of dementia and mild cognitive impairmentJournal of Psychiatric Research, 2009
- Mapping Scores Onto Stages: Mini-Mental State Examination and Clinical Dementia RatingThe American Journal of Geriatric Psychiatry, 2006
- The AD8Neurology, 2005
- The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool For Mild Cognitive ImpairmentJournal of the American Geriatrics Society, 2005
- Validation of diagnostic codes within medical services claimsJournal of Clinical Epidemiology, 2004